Addictions Therapeutics Market Forecast: What to Expect by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Addictions Therapeutics Market Between 2025 And 2029?

The addictions therapeutics market has shown strong expansion in recent years. It is projected to increase from $7.05 billion in 2024 to $7.46 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. The historical development of this market is due to increased consumption of addictive substances such as alcohol, tobacco, and drugs, along with growing awareness and a rise in substance abuse disorders. Additionally, the legalization of marijuana in various regions and enhanced funding and support for addiction treatment programs have contributed to this growth.

The addictions therapeutics market is anticipated to experience substantial expansion over the upcoming years. Projections indicate it will reach $9.57 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.4%. This growth during the forecast period is attributable to several factors, including increasing drug awareness initiatives, the rise of synthetic drugs and novel psychoactive substances, evolving lifestyles and heightened stress levels, the proliferation of rehabilitation centers, and the incorporation of telehealth services into addiction treatment. Key trends anticipated for this period encompass technological progress in diagnostic methods, advancements in neuroscience, strategic alliances and joint ventures among pharmaceutical firms and various stakeholders to tackle addiction challenges, and the introduction of novel drugs for addiction therapeutics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12129&type=smp

Which Drivers Are Supporting Growth Of The Addictions Therapeutics Market?

The addiction therapeutics market is expected to expand moving forward, driven by increasing alcohol consumption. Alcohol consumption is defined as the process of drinking beverages that contain ethyl alcohol. Addiction therapeutics serve to treat alcohol-related addiction, helping individuals consume less alcohol by preventing its depressive effects and promoting a balance between the excitatory and inhibitory neurotransmitters, glutamate and gamma-aminobutyric acid, which ultimately reduces alcohol cravings and eases symptoms like insomnia, anxiety, and restlessness during alcohol withdrawal. As an illustration, a report released by Statistics Canada, a national statistical agency in Canada, in February 2023 revealed that alcoholic beverage sales across retail establishments and liquor authorities totaled $26.1 billion in the fiscal year concluding on March 31, 2022. This figure marked a 2.4% increase from the prior year. Wine sales alone grew by 2.1%, reaching $8.1 billion during the same timeframe. Regarding the market’s composition, beer represented 34.9% of the total alcohol sales value in 2021–2022, with wine at 31.3%, spirits at 25.8%, and ciders and coolers at 8.0%. Thus, the growing consumption of alcohol is propelling the addiction therapeutics market.

How Is The Addictions Therapeutics Market Classified Into Different Segments?

The addictions therapeuticsmarket covered in this report is segmented –

1) By Drug Type: Buprenorphine; Naltrexone; Bupropion; Disulfiram; Nicotine Replacement Products; Varenicline; Other Drugs

2) By Treatment Type: Opioid Addiction Treatment; Alcohol Addiction Treatment; Nicotine Addiction Treatment; Other Substance Addiction Treatment

3) By Treatment Center: Inpatient Treatment Center; Residential Treatment Center; Outpatient Treatment Center

4) By Distribution Channel: Hospital Pharmacies; Medical Stores; Other Distribution Channel

5) By Application: Public; Private; Government

Subsegments:

1) By Buprenorphine: Subutex; Suboxone

2) By Naltrexone: Oral Naltrexone; Extended-Release Naltrexone (Vivitrol)

3) By Bupropion: Wellbutrin; Zyban

4) By Disulfiram: Antabuse

5) By Nicotine Replacement Products: Nicotine Patches; Nicotine Gum; Nicotine Inhalers; Nicotine Lozenges

6) By Varenicline: Chantix (Champix)

7) By Other Drugs: Acamprosate; Topiramate; Gabapentin

What Are The Latest Industry Trends Transforming The Addictions Therapeutics Market?

Major entities within the addiction therapeutics market are developing innovative offerings, such as drugs for cocaine use disorders (CUD), to attract larger customer bases, generate more sales, and increase revenue. Drugs for cocaine use disorders (CUD) are therapeutic agents specifically designed to aid individuals grappling with cocaine addiction or dependence. For example, in January 2023, Tempero Bio, a US-based biopharmaceutical firm, announced the U.S. Food and Drug Administration (FDA) approval for the TMP-301. The distinguishing characteristic of TMP-301, the Company’s investigational compound, lies in its role as a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM). Specifically engineered for a significant role in treating cocaine use disorders (CUD), TMP-301 is notable for its potency, selectivity, and oral availability, all geared towards effectively mitigating the overactive glutamate signaling associated with CUD.

Who Are The Prominent Global Companies Shaping The Addictions Therapeutics Market?

Major companies operating in the addictions therapeutics market include Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Insys Therapeutics Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Braeburn Inc., Titan Pharmaceuticals Inc., BioCorRx Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

Which Region Currently Holds The Largest Share Of The Addictions Therapeutics Market?

North America was the largest region in the addictions therapeutics market in 2024. The regions covered in the addictions therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Addictions Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12129&type=smp

Browse Through More Reports Similar to the Global Addictions Therapeutics Market 2025, By The Business Research Company

Blood Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Rituximab Biosimilar Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rituximab-biosimilar-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795